Late-life body mass index and amyloid interaction on cognitive decline in unimpaired older adults
Open Access
- 8 April 2026
- journal article
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (5) , 100543
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Neurologic Diseases (K23 AG084868)
- Foundation for Neurologic Diseases (5P30AG072975\u201304)
- National Institute on Aging (R01 AG063689)
- National Institutes of Health (U24AG057437)
- National Institutes of Health (U19AG010483)
- National Institutes of Health (K23 AG084868)
- Albert Einstein College of Medicine, Yeshiva University
- Eli Lilly and Company
- Foundation for the National Institutes of Health
- GHR Foundation
- Alzheimer's Association
- Avid Radiopharmaceuticals
- Yulgilbar Foundation
This publication has 75 references indexed in Scilit:
- Plasma Leptin and Alzheimer Protein Pathologies Among Older AdultsJAMA Network Open, 2024
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or DementiaJAMA Neurology, 2022
- Association of Factors With Elevated Amyloid Burden in Clinically Normal Older IndividualsJAMA Neurology, 2020
- Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older AdultsJAMA Neurology, 2017
- Decline in Weight and Incident Mild Cognitive ImpairmentJAMA Neurology, 2016
- The Preclinical Alzheimer Cognitive CompositeJAMA Neurology, 2014
- Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain AgingJAMA, 2009
- Midlife and Late-Life Obesity and the Risk of DementiaArchives of Neurology, 2009
- A 32-Year Prospective Study of Change in Body Weight and Incident DementiaArchives of Neurology, 2005